PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Investigation into safety of new diabetes drugs -- will manufacturers release their data?

Joint BMJ/Channel 4 Dispatches investigation

2013-06-10
(Press-News.org) The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs in industry studies has not been published.

Some independent studies challenge the conclusions of the drugs manufacturers' own research. Now some medical experts and patient groups are calling on the pharmaceutical companies to be more transparent in reporting of study data and to enter into dialogue about safety concerns.

As a result, millions of patients around the world have not been fully informed about some of the possible risks.

Some critics say the drug regulators in Europe and the US have been slow to pursue concerns about the potential adverse effects of these new diabetes drugs, despite the emerging warning signs in the medical literature, regulatory documents, and adverse event databases.

Full details will be published on bmj.com on Monday 10 June and broadcast in Diets, Drugs and Diabetes – Channel 4 Dispatches on Monday 10 June at 8pm on Channel 4.

GLP-1 based drugs are used to treat type 2 diabetes by regulating blood sugar. Some of these drugs also suppress appetite and are currently being tested as a possible treatment for obesity.

In the course of this investigation, the BMJ has reviewed thousands of pages of regulatory documents obtained under freedom of information and found unpublished data pointing to "unwanted proliferative or inflammatory pancreatic effects."

The BMJ has also found that, despite published reports that indicated safety concerns, companies have not done certain critical safety studies; nor have regulators requested them yet. And access to raw data that might help resolve doubts about the safety of these drugs has been denied.

Dr Deborah Cohen, the BMJ's Investigation Editor, says: "On their own the individual pieces of unpublished evidence may seem inconclusive, but when considered alongside other emerging and long standing evidence, a worrying picture emerges, posing serious questions about the safety of this class of drug."

Three publications this year have raised concerns long held by some experts about the potential side effects of GLP-1 based drugs, prompting both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to launch a review into whether the drugs may cause or contribute to the development of pancreatic cancer. And in America, hundreds of people are suing manufacturers alleging that the drugs caused pancreatitis and in some cases cancer.

Yet the evidence is fiercely contested amongst scientists and manufacturers stoutly defending the safety of their products.

Some argue that the published evidence against the drugs is weak, while others say we can't yet be sure that these drugs are safe and are calling for all the study data to be made public for independent analysis.

Research by Professor Peter Butler at the University of California Los Angeles, for example, found worrying changes in the pancreases of animals that received a GLP-1 based drug. He has also found abnormal changes, including pre-cancerous lesions, in the pancreases of eight organ donors taking GLP-1 based drugs compared with patients taking other anti-diabetic drugs.

And studies of side effects reported to the regulators have also started turning up cases of pancreatic cancer among patients on GLP-1 based drugs. Both EMA and the FDA have confirmed to the BMJ that they have "signal" for pancreatic cancer - but this does not mean there is a causal link.

Together these findings raise important and troubling questions about a possible link between these diabetes drugs and pancreatic cancer, but no safety alert has yet been issued by the regulators.

More information is expected later this month, when the US National Institutes of Health hold a two-day meeting on possible links between diabetes, diabetes drugs and pancreatic cancer.

But some consumer groups are calling for the drugs to be withdrawn as a diabetes treatment to prevent potential harm to patients while we wait for this evidence – and they don't want to see them licensed as an obesity treatment.

Writing in the BMJ, Dr Fiona Godlee, Editor in Chief said: "All drug licensing is about balancing benefits and risks. But instead of engaging in open debate about legitimate and important scientific questions, the manufacturers have been unwilling to share their data. Meanwhile patients and doctors have not been kept properly informed about the uncertainties surrounding these drugs."

She adds: "The debate would be much easier to resolve if all the information was placed in the public domain so scientists, doctors and ultimately patients could make up their own minds."

In an editorial in the BMJ, Edwin Gale, Professor of diabetic medicine, says this shows once again that current regulatory procedures are inadequate to deal with the challenge of drug treatments that have more than one biological target, which he calls "shotgun therapies." He says: "Similar scenarios will be re-enacted while secrecy rules and the companies control access to the data."

In statements to Channel 4 Dispatches airing tonight, the drug companies all maintain their commitment to patient safety. On monitoring, the companies all say they have regular, close and vigorous safety processes in place, including large scale, long term trials, and the results are routinely submitted to the regulatory authorities.

INFORMATION:

The BMJ is campaigning for improved access to data from clinical trials - see bmj.com/opendata

If patients have any concerns about the diabetes drugs they are taking, they are asked to consult with a doctor before changing their medication.

END



ELSE PRESS RELEASES FROM THIS DATE:

Scientists identify potential drug target for treatment-resistant anemias

2013-06-10
CAMBRIDGE, Mass. (June 9, 2013) – Researchers at Whitehead Institute have identified a protein that is the target of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy. The discovery could spur development of drugs capable of increasing this protein's production without causing the severe side effects associated with glucocorticoids. "This research is medically important, and we are using it to find a better way ...

How to control maple tree pests using integrated pest management

2013-06-10
Many maple trees share a suite of important arthropod pests that have the potential to reduce the trees' economic and aesthetic value. Now a new open-access article in the Journal of Integrated Pest Management offers maple tree owners information about the biology, damage, and management for the most important pests of maples with an emphasis on integrated pest management (IPM) tactics for each pest. In the article, entitled "Biology, Injury, and Management of Maple Tree Pests in Nurseries and Urban Landscapes," the authors identify 81 potentially damaging arthropod ...

Potentially 'catastrophic' changes underway in Canada's northern Mackenzie River Basin: report

2013-06-10
Canada's Mackenzie River basin -- among the world's most important major ecosystems -- is poorly studied, inadequately monitored, and at serious risk due to climate change and resource exploitation, a panel of international scientists warn today. In a report, nine Canadian, US and UK scientists convened by the US-based Rosenberg International Forum on Water Policy, say effective governance of the massive Basin, comprising an area three times larger than France -- holds enormous national and global importance due to the watershed's biodiversity and its role in hemispheric ...

Nearly a fifth of designated drivers are impaired

2013-06-10
PISCATAWAY, NJ – They may volunteer to be the one to get their friends home safely, but "designated drivers" often drink—even to a level that impairs them behind the wheel, according to a report in the July issue of the Journal of Studies on Alcohol and Drugs. The study, of more than 1,000 bar patrons, found that approximately 40 percent of designated drivers had downed alcohol. What's more, most of those drinkers had blood alcohol levels that could impair their driving. It's not clear why those designated drivers drank despite their role. Some of them might think that ...

Women can be screened years later than men with 'virtual colonoscopy'

2013-06-10
A new study has found that women can be screened for colorectal cancer at least five to 10 years later than men when undergoing an initial "virtual colonoscopy." Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help establish guidelines for the use of this screening technique, which is less invasive than a traditional colonoscopy. Detecting precancerous polyps through the use of imaging techniques such as a traditional colonoscopy may prevent colorectal cancer. However, some people may feel that this technique ...

Transcendental Meditation positively impacts student graduation rates, new research shows

2013-06-10
A new study published in the June 2013 issue of the journal Education (Vol. 133, No. 4)* shows practice of the Transcendental Meditation® technique was associated with higher graduation rates, compared to controls. Higher graduation rates affect not only the academic and personal life of the individual students, but also society as a whole. Graduation (versus dropping out) from high school translates into higher earning potential, less crime and incarceration, and less dependence on government assistance programs. The most recent data shows that only 69 percent of ...

Designated drivers don't always abstain, UF study finds

2013-06-10
GAINESVILLE, Fla. --- Maybe better call that cab, after all: A new University of Florida study found that 35 percent of designated drivers had quaffed alcohol and most had blood-alcohol levels high enough to impair their driving. Adam Barry, an assistant professor of health education and behavior at UF, and his team interviewed and breath-tested more than 1,000 bar patrons in the downtown restaurant and bar district of a major university town in the Southeast. Of the designated drivers who had consumed alcohol, half recorded a blood-alcohol level higher than .05 percent ...

When calculating cell-growth thermodynamics, reconsider using the Gibbs free energy equation

2013-06-10
A forthcoming article in The Quarterly Review of Biology provides the basis for an argument against using the Gibbs free energy equation to accurately determine the thermodynamics of microbial growth. Microbial growth is a biological process that has been previously treated as a chemical reaction operating in accord with the Gibbs free energy equation, developed during the 1870s. The heat of yeast growth was the first to be measured by direct calorimetry, in 1856. However, the full application of the Gibbs equation to microbial growth did not occur until 1997, with the ...

Discovery may lead to new treatments for jaundice

2013-06-10
Helping to protect newborns and older patients against more severe effects of jaundice is the hope of University of Guelph researchers, who have shown how a liver enzyme protects cells from damage caused by the condition. Their discovery might ultimately lead to an alternative treatment for jaundice, such as a new drug or supplement, says Daniel Kim, a research technician in Guelph's Department of Biomedical Sciences. He is lead author of a paper published recently in the journal Toxicology and Applied Pharmacology. Co-authors are biomedical sciences professor Gordon ...

The Vitamin Mineral Shop LLC Celebrates Its Third Anniversary

2013-06-10
Three years ago, in June 2010, the Vitamin Mineral Shop, LLC and its website http://www.vitaminmineralshop.com were launched. Since then, the web site has grown with the number of Vitamin Power products offered, and from additional related information being added. "The first three years have been an unique experience. The internet search environment has changed. The simple techniques that worked in the past no longer work, and some have a negative impact. For this upcoming fourth year, the website will have new pages added, and existing pages will be rewritten to ...

LAST 30 PRESS RELEASES:

Rare bird skull from the age of dinosaurs helps illuminate avian evolution

Researchers find high levels of the industrial chemical BTMPS in fentanyl

Decoding fat tissue

Solar and electric-powered homes feel the effects of blackouts differently, according to new research from Stevens

Metal ion implantation and laser direct writing dance together: constructing never-fading physical colors on lithium niobate crystals

High-frequency enhanced ultrafast compressed photography technology (H-CAP) allows microscopic ultrafast movie to appear at a glance

Single-beam optical trap-based surface-enhanced raman scattering optofluidic molecular fingerprint spectroscopy detection system

Removing large brain artery clot, chased with clot-buster shot may improve stroke outcomes

A highly sensitive laser gas sensor based on a four-prong quartz tuning fork

Generation of Terahertz complex vector light fields on a metasurface driven by surface waves

Clot-busting meds may be effective up to 24 hours after initial stroke symptoms

Texas Tech Lab plays key role in potential new pathway to fight viruses

Multi-photon bionic skin realizes high-precision haptic visualization for reconstructive perception

Mitochondria may hold the key to curing diabetes

Researchers explore ketogenic diet’s effects on bipolar disorder among teenagers, young adults

From muscle to memory: new research uses clues from the body to understand signaling in the brain

New study uncovers key differences in allosteric regulation of cAMP receptor proteins in bacteria

Co-located cell types help drive aggressive brain tumors

Social media's double-edged sword: New study links both active and passive use to rising loneliness

An unexpected mechanism regulates the immune response during parasitic infections

Scientists enhance understanding of dinoflagellate cyst dormancy

PREPSOIL promotes soil literacy through education

nTIDE February 2025 Jobs Report: Labor force participation rate for people with disabilities hits an all-time high

Temperamental stars are distorting our view of distant planets

DOE’s Office of Science is now Accepting Applications for Office of Science Graduate Student Research Awards

Twenty years on, biodiversity struggles to take root in restored wetlands

Do embedded counseling services in veterinary education work? A new study says “yes.”

Discovery of unexpected collagen structure could ‘reshape biomedical research’

Changes in US primary care access and capabilities during the COVID-19 pandemic

Cardiometabolic trajectories preceding dementia in community-dwelling older individuals

[Press-News.org] Investigation into safety of new diabetes drugs -- will manufacturers release their data?
Joint BMJ/Channel 4 Dispatches investigation